BackInnoCan Pharma Overview

InnoCan Pharma Long Term Debt

Track InnoCan Pharma's long-term debt ($990K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$994804.00
↓ 28.64% YoYΔ $-399196.00 vs prior year quarter

Peer trimmed avg / median

Loading

InnoCan Pharma Long Term Debt History

Loading

InnoCan Pharma vs. peers: Long Term Debt Comparison

Loading

InnoCan Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InnoCan Pharma (INNPF) FAQ

As of the most recent data (June 2026), INNPF shows a long-term debt of $990K. That compares with $1.4M in the prior-year period — down 28.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INNPF's long-term debt is now $990K (was $1.4M) — a 28.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InnoCan Pharma is outperforming or lagging.

Tracking INNPF's long-term debt over time shows whether InnoCan Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $990K That compares with $1.4M in the prior-year period — down 28.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has InnoCan Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $990K) with ownership activity and broader fundamentals.

Questions & Answers